Back
Enlivex Therapeutics 10K Form
Sell
17
ENLV
Enlivex Therapeutics
Last Price:
1.06
Seasonality Move:
14.56%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ENLV News And Ratings
See the #1 stock for the next 7 days that we like better than ENLV
ENLV Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-1.81M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.37 |
| Price / Book: | 0.8 |
Profitability
| EPS (TTM): | -1.18000 |
|---|---|
| Net Income (TTM): | $-22.29M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Enlivex Therapeutics Earnings Forecast
Key Enlivex Therapeutics Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 12 years have been positive in 7 years.
Enlivex Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ENLV |
| CUSIP: | M4130Y |
| Website: | enlivex.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ENLV Technical Analysis vs Fundamental Analysis
Sell
17
Enlivex Therapeutics (ENLV)
is a Sell
Is Enlivex Therapeutics a Buy or a Sell?
-
Enlivex Therapeutics stock is rated a Sell
The current Enlivex Therapeutics [ENLV] share price is $1.07. The Score for ENLV is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.